Indraprastha Medical Corporation Share Price
354.85-1.50 (-0.42%)
-25.75% past 1 Year
Indraprastha Medical Corpn. Ltd offers a range of diagnostic, medical, and surgical facilities for the care of their patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology,
Corporate filings & documents
Announcements
we hereby submit copies of the public notice of the 38th AGM published in the finacial express all India editions in english language and in jansatta delhi edition in hindi language
1 day agowe hereby submit copies of the public notice of the 38th AGM published in the finacial express all India editions in english language and in jansatta delhi edition in hindi language
1 day agoPursuant to Regulation 34(1)(a) & 53(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Annual Report of the Company for the financial yearended 31st March 2026 along with the Notice of the 38th Annual General Meeting (AGM) to be held on 24th September 2026 and Business Responsibility and Sustainability Report forthe financial year 2025-26 is attached.
3 days agoPursuant to Regulation 34(1)(a) & 53(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Annual Report of the Company for the financial yearended 31st March 2026 along with the Notice of the 38th Annual General Meeting (AGM) to be held on 24th September 2026 and Business Responsibility and Sustainability Report forthe financial year 2025-26 is attached.
3 days agoEnclosed please find the Annual Report of the company for the financial year ended 31st March 2026 along with the notice of the 38th AGM to be held on 24th September 2026 and Business Responsiblity and Sustainabilty Report for the finacial year 2025-2026.
3 days agoEnclosed please find the Annual Report of the company for the financial year ended 31st March 2026 along with the notice of the 38th AGM to be held on 24th September 2026 and Business Responsiblity and Sustainabilty Report for the finacial year 2025-2026.
3 days ago1)The AGM of the Company will be held on Thursday 24th September 2026.2) The Record date for purpose of declaration of Dividend is 18th September 2026.3) The cut-off date for determining the members eligible to vote is 18th September 2026.
5 days ago1)The AGM of the Company will be held on Thursday 24th September 2026.2) The Record date for purpose of declaration of Dividend is 18th September 2026.3) The cut-off date for determining the members eligible to vote is 18th September 2026.
5 days agowe hereby submit copies of the public notice of the Financial results published on 7th August 2026 in the "Financial Express" all India Editions in English Language and in " Jansatta" in Delhi Edition in Hindi Language.
4 weeks agowe hereby submit copies of the public notice of the Financial results published on 7th August 2026 in the "Financial Express" all India Editions in English Language and in " Jansatta" in Delhi Edition in Hindi Language.
4 weeks agoThe board of directors of the company has at its meeting held on 6th August 2026 considered and approved convening the 38th AGM of the company on 24th September 2026 through Video Conferencing\ other audio- visual means
4 weeks agoThe board of directors of the company has at its meeting held on 6th August 2026 considered and approved convening the 38th AGM of the company on 24th September 2026 through Video Conferencing\ other audio- visual means
4 weeks agoThe board of director of the company as its meeting held on 06-08-2026 considered and approved fixation of record date as Friday 18-09-2026 for the purpose of payment of dividend for the year 2025-26.
4 weeks agoThe board of director of the company as its meeting held on 06-08-2026 considered and approved fixation of record date as Friday 18-09-2026 for the purpose of payment of dividend for the year 2025-26.
4 weeks agoThis is to inform that the Board of Directors of the Company has at its meeting held on Thursday 6th August 2026 (i.e. today) inter-alia considered and approved the following items: 1. The Un-audited Financial Results of the Company for the quarter ended 30th June 2026. 2. Convening Annual General Meeting 3. Fixation of Record Date4. Appointment of Cost Auditors This is for your information and record.
4 weeks agoThis is to inform that the Board of Directors of the Company has at its meeting held on Thursday 6th August 2026 (i.e. today) inter-alia considered and approved the following items: 1. The Un-audited Financial Results of the Company for the quarter ended 30th June 2026. 2. Convening Annual General Meeting 3. Fixation of Record Date4. Appointment of Cost Auditors This is for your information and record.
4 weeks agoIndraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve It is hereby informed that a meeting of the Board of Directors of the Company will be held on Thursday 6th August 2026 inter-alia to consider and approve the un-audited financial results for the quarter ended 30th June 2026.
1 month agoIndraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve It is hereby informed that a meeting of the Board of Directors of the Company will be held on Thursday 6th August 2026 inter-alia to consider and approve the un-audited financial results for the quarter ended 30th June 2026.
1 month agoEnclosed please find herewith a certificate dated 6th July 2026 issued M/s MUFG Intime india Private Limited Registrar And Share transfer agent of the company quarter ended 30th June 2026.
1 month agoEnclosed please find herewith a certificate dated 6th July 2026 issued M/s MUFG Intime india Private Limited Registrar And Share transfer agent of the company quarter ended 30th June 2026.
1 month agoit is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons from Wednesday 1 st July 2026 till 48 hours after the announcement/deceleration of the un-audited financial results for the quarter ending 30th June 2026.
2 months agoit is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons from Wednesday 1 st July 2026 till 48 hours after the announcement/deceleration of the un-audited financial results for the quarter ending 30th June 2026.
2 months agoWe wishh to inform you that the management of the company intends to engage in discussions with investors/analyst meet on 4th June 2026 & 5th June 2026 at Mumbai. Further please note that no unpublished price sensitive information pertaning to the company will be shared at aforesaid meet.
3 months agoWe wishh to inform you that the management of the company intends to engage in discussions with investors/analyst meet on 4th June 2026 & 5th June 2026 at Mumbai. Further please note that no unpublished price sensitive information pertaning to the company will be shared at aforesaid meet.
3 months agowe wish to inform you that ICRA Limited has vide its letter dated 26th May 2026 re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation Limited at "[ICRA]AA(Stable)" and the short term rating at [ICRA]A1+.
3 months agowe wish to inform you that ICRA Limited has vide its letter dated 26th May 2026 re-affirmed its rating on the long term bank facility and instrumnet of Indraprasth Medical Corporation Limited at "[ICRA]AA(Stable)" and the short term rating at [ICRA]A1+.
3 months agoWe hereby submit copies of the public notice of the financial results published on 13th May 2026 in the "Financial Express" all India editions in English Language and in " Jansatta" Delhi edition in Hindi language.
3 months agoWe hereby submit copies of the public notice of the financial results published on 13th May 2026 in the "Financial Express" all India editions in English Language and in " Jansatta" Delhi edition in Hindi language.
3 months agothe board of directors of the company inter-alia :1. Approved the audited finacial results for the quater/year ended 31st March 2026 2. Reccomended a dividend @ 40% i.e. Rs 4 per equity shares for the finacial year 2025-2026 subject to approval of shareholders at the AGM of the company.
3 months agothe board of directors of the company inter-alia :1. Approved the audited finacial results for the quater/year ended 31st March 2026 2. Reccomended a dividend @ 40% i.e. Rs 4 per equity shares for the finacial year 2025-2026 subject to approval of shareholders at the AGM of the company.
3 months agoIndraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 12th May 2026 inter alia: -a) to consider and approve the audited financial results for the quarter/ year ended 31st March 2026; andb) to consider and recommend dividend if any on equity shares of the Company for the financial year 2025-26.This is for your information and record.
4 months agoIndraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 12th May 2026 inter alia: -a) to consider and approve the audited financial results for the quarter/ year ended 31st March 2026; andb) to consider and recommend dividend if any on equity shares of the Company for the financial year 2025-26.This is for your information and record.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Indraprastha Medical Corporation Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232DL1988PLC030958</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PRIYA RANJAN <br/> Designation: AVP CORPORATE AFFAIRS AND LEGAL <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: C P TYAGI <br/> Designation: CHEIF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 23/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Indraprastha Medical Corporation Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232DL1988PLC030958</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PRIYA RANJAN <br/> Designation: AVP CORPORATE AFFAIRS AND LEGAL <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: C P TYAGI <br/> Designation: CHEIF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 23/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoPlease find herewith a certificate dated 1st April 2026 issued by M/s MUFG Intime India Private Limited Registrar & Transfer Agent of the Company for the quarter ended 31st March 2026.
4 months agoPlease find herewith a certificate dated 1st April 2026 issued by M/s MUFG Intime India Private Limited Registrar & Transfer Agent of the Company for the quarter ended 31st March 2026.
4 months agoWe enclose herewith copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares published on 7th April 2026 in the Financial express all India editions in English Language and in Jansatta Delhi edition in Hindi language. This is for your information and record.
4 months agoWe enclose herewith copies of the public notice of the request received under Special window for re-lodgment of transfer request for physical shares published on 7th April 2026 in the Financial express all India editions in English Language and in Jansatta Delhi edition in Hindi language. This is for your information and record.
4 months agoWe hereby inform you that Mr. Vinayak Chatterjee (DIN: 00008933) has completed his tenure viz. second term of five consecutive years on 31st March 2026 as Independent Director on the Board of Directors of the Company. Consequently he ceases to be the Director of the Company and Member/Chairperson of the respective committees of the Board at the end of the day on 31st March 2026.
5 months agoWe hereby inform you that Mr. Vinayak Chatterjee (DIN: 00008933) has completed his tenure viz. second term of five consecutive years on 31st March 2026 as Independent Director on the Board of Directors of the Company. Consequently he ceases to be the Director of the Company and Member/Chairperson of the respective committees of the Board at the end of the day on 31st March 2026.
5 months agoWe wish to inform you that financial results for the quarter and year ending on 31st March 2026 along with other matters for which trading window is required to be closed from Wednesday 1st April 2026 till 48 hours after the announcement/ declaration of the audited financial results.
5 months agoWe hereby submit voting results of the Postal Ballot Notice dated 3rd February 2026 along with copy of the Scrutinizer report dated 21st march 2026
5 months agoWe hereby submit voting results of the Postal Ballot Notice dated 3rd February 2026 along with copy of the Scrutinizer report dated 21st march 2026
5 months agoWe hereby submit copies of the public notice of the postal Ballot published on 20th Februrary 2026 in the Financial Express all India Editions and in Jansatta Delhi edition.
6 months agoEnclosed please find notice for Postal ballot. Seeking approvals of shareholders for appointment/ reappointment of independent directors as per details given in attached notice of postal ballot.
6 months agoEnclosed please find notice for Postal ballot. Seeking approvals of shareholders for appointment/ reappointment of independent directors as per details given in attached notice of postal ballot.
6 months agoWe hereby submits the copy of public notice of financial results published on 4th February 2026 in Financial Express all India editions in English language and in Jansatta Delhi edition in Hindi language.
7 months agoIt is hereby informed the board of directors in its meeting held on 03.02.2026 considered and approved the appionment/ re-appiontment of the following :1. Mr. Harsh Pati Singhania as Additional Director in the catergory of Non Executive Independent Director for a term of 5 years 2. Mr. Salil singhal as Independent director for a second term of 5 years. 3. Ms Vineeta Rai as Independent director for a second term of 5 years.4. Ms Madhumita Ganguli as Independent director for a second term of 5 years
7 months agoPursuant to Regulation 30 and 33 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the Company at its meeting held on Tuesday the 3rd February 2026 i.e. today considered and approved the following :-1. Considered and approved unaudited financial results of the Company for the quarter and nine months ended on 31st December 2025.2. Noted additional affidavit filed by Govt. of NCT of Delhi in the pending Free Patient Matter i.e. SLP (C) No. 29482/2009.3. Appointed Mr. Harsh Pati Singhania as an additional Director in the category of Non-executive Independent Director for a period of five years.4. Reappointed Mr. Salil Singhal as an Independent Director for second consecutive term of five years.5. Reappointed Ms. Vineeta Rai as an Independent Director for second consecutive term of five years.6. Reappointed Ms. Madhumita Ganguli as Independent Director for second consecutive term of five years.
7 months agoIndraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve It is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 3rd February 2026 to consider and approve quarterly financial results for the quarter ended 31-12-2025.
7 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2026-09-18
Dividend
4.0
2025-09-18
Dividend
4.5
2024-09-13
Dividend
4.5
2023-09-15
Dividend
3.0
2022-09-15
Dividend
2.5
2019-09-12
Dividend
1.6
2018-09-12
Dividend
1.5
2017-09-14
Dividend
1.8
2016-08-18
Dividend
1.8
2015-09-16
Dividend
1.8
2014-09-18
Dividend
1.8
2013-09-19
Dividend
1.6
2012-09-06
Dividend
1.6
2011-09-05
Dividend
1.6
2010-08-30
Dividend
1.6
Company details
Registered office
Sarita Vihar Delhi - Mathura Road NULL New Delhi Delhi PIN: 110076 Tel No: 011- 26925858 / 26925801 Fax No: 011- 26823629 Email: [email protected] Internet: https://www.apollohospitals.com/
Registrars
Noble Heights, 1st Floor, Plot NH 2C-1 Block LSC, Near Savitri MarketJanakpuriNew Delhi-11005891-4141-0592/93/9491-4141-0591 Noble Heights, 1st Floor, Plot NH 2 C-1 Block LSC, Near Savitri Market Janakpuri PIN: Tel No: 91-4141-0592/93/94 Fax No: 91-4141-0591 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Prathap C Reddy, Vice Chairman
Shivakumar Pattabhiraman, Managing Director
Harsh Pati Singhania, Non Executive Independent Director
Madhumita Ganguli, Non Executive Independent Director
Mahesh Verma, Non Independent & Non Executive Director
Salil Singhal, Non Executive Independent Director
Sandip Somany, Non Executive Independent Director
Sangita Reddy, Non Independent & Non Executive Director
Sudhir Jalan, Non Executive Independent Director
Suneeta Reddy, Non Independent & Non Executive Director
Tejpreet Singh Chopra, Non Executive Independent Director
Vineeta Rai, Non Executive Independent Director
Priya Ranjan, Company Secretary & Compliance Officer
Details
BSE 532150
NSE INDRAMEDCO
ISIN INE681B01017